Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs17860142 | chr21:34607870 | C/G | 0.000294 | 172 | 21.9 | 31.97 | 25.17 | KM Plot |
PCPG | rs17860165 | chr21:34611730 | C/T | 0.000286 | 176 | 21.9 | 31.2 | 25.08 | KM Plot |
PCPG | rs1796524 | chr6:26449219 | G/A | 6.01E-7 | 178 | 24.53 | 32.6 | 10.68 | KM Plot |
PCPG | rs1799881 | chr16:71602471 | T/C | 1.01E-5 | 174 | 24.85 | 30.93 | 14.5 | KM Plot |
PCPG | rs1800331 | chr16:89858417 | C/A | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs1800339 | chr16:89839637 | C/A | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs1800344 | chr16:89816367 | T/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs1800355 | chr16:89813194 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs1802236 | chr12:56679751 | A/G | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs1805051 | chr3:195778972 | C/T | 2.07E-11 | 173 | 24.62 | 36 | 6.87 | KM Plot |
PCPG | rs181006907 | chr12:56689535 | G/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs181042982 | chr7:1110350 | G/GCA | 0.000259 | 174 | 25.7 | 24.95 | 49.58 | KM Plot |
PCPG | rs1811322 | chr16:56639705 | A/T | 0.000211 | 178 | 25.87 | 23.58 | 24.23 | KM Plot |
PCPG | rs1813653 | chr3:80579175 | A/G | 6.94E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs182251041 | chr16:89907164 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |